Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,978,000 | 1,888,000 | 1,843,000 | 1,768,000 | 1,887,000 |
| Cost of Goods | 574,000 | 539,000 | 540,000 | 520,000 | 560,000 |
| Gross Profit | 1,404,000 | 1,349,000 | 1,303,000 | 1,248,000 | 1,327,000 |
| Operating Expenses | 1,631,000 | 1,648,000 | 1,084,000 | 1,224,000 | 1,820,000 |
| Operating Income | -227,000 | -299,000 | 219,000 | 24,000 | -493,000 |
| Interest Expense | 60,000 | 58,000 | 106,000 | 60,000 | 55,000 |
| Other Income | -50,000 | -10,000 | -8,000 | -15,000 | -6,000 |
| Pre-tax Income | -337,000 | -367,000 | 105,000 | -51,000 | -554,000 |
| Income Tax | -195,000 | -169,000 | 3,000 | -50,000 | -255,000 |
| Net Income Continuous | -142,000 | -198,000 | 102,000 | -1,000 | -299,000 |
| Net Income | $-142,000 | $-198,000 | $102,000 | $-1,000 | $-299,000 |
| EPS Basic Total Ops | -0.11 | -0.15 | 0.08 | 0.00 | -0.22 |
| EPS Basic Continuous Ops | -0.11 | -0.15 | 0.08 | 0.00 | -0.23 |
| EPS Diluted Total Ops | -0.11 | -0.15 | 0.08 | 0.00 | -0.22 |
| EPS Diluted Continuous Ops | -0.11 | -0.15 | 0.07 | 0.00 | -0.22 |
| EBITDA(a) | $-227,000 | $-299,000 | $219,000 | $24,000 | $-493,000 |